Texas A&M University researchers have developed a novel laser-based spectroscopic technique, dubbed "TRIP," engineered to precisely quantify noncovalent quantum forces. An interdisciplinary team from the Institute for Quantum Science and Engineering, alongside departments of Chemistry, Biology, and Electrical & Computer Engineering, spearheaded this innovation. TRIP spectroscopy facilitates the direct measurement of critical aromatic π-π stacking interactions1, which are fundamental to the architecture and function of proteins and their complexes. The technique has been specifically applied to characterize these forces within the dimers of SARS-CoV-2 main protease (Mpro), demonstrating its utility in complex biological systems. This capability is crucial for understanding molecular recognition and stability at an atomic level, providing deep insights into how biomolecules interact. The accurate quantification of these subtle quantum forces offers a substantial leap forward for pharmaceutical research. Such precision could significantly accelerate rational drug discovery by providing unparalleled insights into the specific binding mechanisms between potential drug candidates and target proteins, potentially reducing experimental trial and error.
Texas A&M Researchers Invent Laser-Based ‘TRIP’ Spectroscopy to Quantify Noncovalent Quantum Forces in Drug Discovery
⚡ High Priority
Why This Matters
(B) Overview of the workflow using TRIP for direct measurement of π-π stacking in the dimers of SARS-CoV-2 main protease, Mpro.
References
- Quantum Computing Report. (2026, June 30). Texas A&M Researchers Invent Laser-Based ‘TRIP’ Spectroscopy to Quantify Noncovalent Quantum Forces in Drug Discovery. *Quantum Computing Report*. https://quantumcomputingreport.com/texas-am-researchers-invent-laser-based-trip-spectroscopy-to-quantify-noncovalent-quantum-forces-in-drug-discovery/
Original Source
Quantum Computing Report
Read original →